Venous thromboembolism after major cancer surgery: Temporal trends and patterns of care

JAMA Surgery

Volumn 149, Issue 1, 2014, Pages 43-49

  Trinh, Vincent Q ^a   Karakiewicz, Pierre I ^a   Sammon, Jesse ^b   Sun, Maxine ^a   Sukumar, Shyam ^b   Gervais, Mai Kim ^a   Shariat, Shahrokh F ^c   Tian, Zhe ^a   Kim, Simon P ^d   Kowalczyk, Keith J ^e   Hu, Jim C ^f   Menon, Mani ^b   Trinh, Quoc Dien ^g  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; CHARLSON COMORBIDITY INDEX; COLON RESECTION; CYSTECTOMY; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; HYSTERECTOMY; LUNG RESECTION; MALE; MORTALITY; PANCREAS RESECTION; PREVALENCE; PRIORITY JOURNAL; PROSTATECTOMY; RACE DIFFERENCE; VENOUS THROMBOEMBOLISM; AGED; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDY; TIME;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84892752072     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3172     Document Type: Article

References (34)

1. Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302(6778):709-711.
2. Alikhan R, Peters F, Wilmott R, Cohen AT. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol. 2004;57(12): 1254-1257.
3. Spyropoulos AC, Hurley JS, Ciesla GN, de Lissovoy G. Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest. 2002;122(1):108-114.
4. Gould MK, Garcia DA,Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2)(SUPPL.):e227S-e277S.
5. Osborne NH,Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol. 2008;15(12): 3567-3578.
6. Bergqvist D, Caprini JA, Dotsenko O, Kakkar AK, Mishra RG,Wakefield TW. Venous thromboembolism and cancer. Curr Probl Surg. 2007;44(3):157-216.
7. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78(5):285-291.
8. Agnelli G, Bolis G, Capussotti L, et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg. 2006;243(1):89-95.
9. Kakkar AK, Haas S,Wolf H, Encke A. Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: theMC-4 cancer substudy. Thromb Haemost. 2005;94(4):867-871.
10. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Arch Surg. 1992;127(3):310-313.
11. Bergqvist D. Venous thromboembolism and cancer: prevention of VTE. Thromb Res. 2001;102(6):V209-V213.
12. Kakkar AK. Prevention of venous thromboembolism in the cancer surgical patient. J Clin Oncol. 2009;27(29):4881-4884.
13. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(3):446-455.
14. SilversteinMD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ III. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158(6):585-593.
15. Healthcare Cost and Utilization Project (HCUP). Nationwide Inpatient Sample (NIS). 2009. http://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed June 1, 2012.
16. Lin HC, Lee HC. Caseload volume-outcome relation for pulmonary embolism treatment: association between physician and hospital caseload volume and 30-day mortality. J Thromb Haemost. 2008;6(10):1707-1712.
17. CharlsonME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
19. Healthcare Cost and Utilization Project (HCUP). NIS description of data elements. http://www.hcup-us.ahrq.gov/db/nation/nis /nisdde.jsp. Accessed June 1, 2012.
20. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17):1723-1728.
21. Panageas KS, Schrag D, Riedel E, Bach PB, Begg CB. The effect of clustering of outcomes on the association of procedure volume and surgical outcomes. Ann Intern Med. 2003;139(8):658-665.
22. Deitelzweig SB, Johnson BH, Lin J, Schulman KL. Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. Am J Hematol. 2011;86(2):217-220.
23. Stein PD, Matta F, Dalen JE. Is the campaign to prevent VTE in hospitalized patients working? Chest. 2011;139(6):1317-1321.
24. Qaseem A, Snow V, Barry P, et al. Joint American Academy of Family Physicians/American College of Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2007;146(6):454-458.
25. Heit JA, Beckman MG, Bockenstedt PL, et al. CDC Thrombosis and Hemostasis Centers Research and Prevention Network. Comparison of characteristics from white-and black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol. 2010;85(7):467-471.
26. Austin H, De Staercke C, Lally C, Bezemer ID, Rosendaal FR, HooperWC. New gene variants associated with venous thrombosis: a replication study in white and black Americans. J Thromb Haemost. 2011;9(3):489-495.
27. Trinh QD, Sun M, Sammon J, et al. Disparities in access to care at high-volume institutions for uro-oncologic procedures. Cancer. 2012;118(18):4421-4426.
28. Wun T, White RH. Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors. Cancer Invest. 2009;27(SUPPL. 1):63-74.
29. Kakkar AK, Williamson RC. Prevention of venous thromboembolism in cancer patients. Semin Thromb Hemost. 1999;25(2):239-243.
30. Lave JR, Lave LB. The extent of role differentiation among hospitals. Health Serv Res. 1971;6(1):15-38.
31. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
32. Nielsen HK, Husted SE, Krusell LR, Fasting H, Charles P, Hansen HH. Silent pulmonary embolism in patients with deep venous thrombosis: incidence and fate in a randomized, controlled trial of anticoagulation versus no anticoagulation. J Intern Med. 1994;235(5):457-461.
33. Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data: is it valid? Med Care. 2000;38(8):785-795.
34. White RH, GarciaM, Sadeghi B, et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res. 2010;126(1):61-67.